Division Director of Medical Oncology at Winship/Director Glenn Family Breast Center/Opinions=my own
Atlanta, Georgia
Joined January 2019
- Tweets215
- Following150
- Followers2.4K
- Likes1.5K
Kevin Kalinsky, MD, MS, FASCO retweeted
Coming up this week! Join us Sept. 19 for the Atlanta Breast Cancer Conference, co-chaired by Winship experts Kevin Kalinsky, MD, MS; Tari King, MD; and Reshma Jagsi, MD, DPhil.
There’s still time to register! Learn more ➡️ bioascend.com/atlanta-breast
Team effort! @SWOG @WinshipAtEmory
🆕article in press: Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER) @KalinskyKevin
Looking forward to this meeting!
Our 5th Annual National General Medical Oncology Summit will be a one-of-a-kind offering, featuring a multidisciplinary faculty of clinical investigators and a blend of short presentations, lively moderated panel discussions and dedicated Q&A. Register: researchtopractice.com/Meeti…
Kevin Kalinsky, MD, MS, FASCO retweeted
.@eaonc is hosting a webinar on EA1241, a companion study for pts previously enrolled in TAILORx or RxPONDER. Investigators & #ClinicalResearch professionals are invited to register below.
📅Feb 4 | 4 PM ET
🎙 @jsparano, @KalinskyKevin, @RimapatelMD
🔗bit.ly/EA1241webinar
Join me at the 43rd Annual Miami Breast Cancer Conference! I'll be sharing insights alongside top experts to advance breast cancer care. Use my last name discount code for FREE registration. Register today: gotoper.com/mbccfof #MBCC25 #BreastCancerCare #BCSM
Kevin Kalinsky, MD, MS, FASCO retweeted
#ClinicalTrial EA1241 is evaluating tissue samples from past TAILORx & RxPONDER trial participants who experienced a recurrence. This research aims to uncover why #BreastCancer returns after treatment. bit.ly/EA1241 cc: @jsparano, @KalinskyKevin, @RimapatelMD
Kevin Kalinsky, MD, MS, FASCO retweeted
#ClinicalTrial EA1241 is evaluating tissue samples from past TAILORx & RxPONDER trial participants who experienced a recurrence. This research aims to uncover why #BreastCancer returns after treatment. bit.ly/EA1241 cc: @jsparano, @KalinskyKevin, @RimapatelMD
Kevin Kalinsky, MD, MS, FASCO retweeted
From #ASH —> #SABCS25! Look forward to seeing how this is going to change/inform our practice in breast cancer!!
In Person: Dec 10, 2025
⏰ Time: 7-9PM
✅ Register here: bit.ly/aiosabcs25
#OncTwitter #MedTwitter #bcsm #AdvInOnc25 @OncUpdates @OncoAlert
Kevin Kalinsky, MD, MS, FASCO retweeted
Trial Activation: EA1241, led by @jsparano of @MountSinaiNYC, is a companion study for patients who previously took part in either the TAILORx or RxPONDER #BreastCancer trials. For more information: bit.ly/EA1241 cc: @KalinskyKevin, @RimapatelMD
Kevin Kalinsky, MD, MS, FASCO retweeted
Getting ready for @OncLive #BTGBreast25 tomorrow. Let's do some polling questions! #MJHLifeSciences @jhaveri_komal @KalinskyKevin @Neil_Iyengar @JAMouabbi
When considering de-escalation in HER2+ early breast cancer, which factor most influences your decision?
16%Residual disease burden
47%pCR + clinical features
11%Genomic risk scores
26%Toxicity concerns
19 votes • Final results Kevin Kalinsky, MD, MS, FASCO retweeted
Getting ready for @OncLive #BTGBreast25 tomorrow. Let's do some polling questions! #MJHLifeSciences @jhaveri_komal @KalinskyKevin @Neil_Iyengar @JAMouabbi
Are TIL levels currently influencing your treatment decisions in #TNBC in clinical practice? #breastcancer
21%Routinely considered
26%Sometimes considered
26%Rarely/only in trials
26%Not yet incorporated
19 votes • Final results Kevin Kalinsky, MD, MS, FASCO retweeted
In this episode of 5-Minute Journal Club, Dr Neil Love is joined by Dr Kevin Kalinsky to define the future role of TROP2-directed antibody-drug conjugates in breast cancer. Watch or listen here: ow.ly/5R5W50X4iy9
Kevin Kalinsky, MD, MS, FASCO retweeted
We kick-off the inaugural Atlanta Breast Cancer Conference with @KalinskyKevin welcoming attendees to discuss the care of multiple breast cancer subtypes.
#AtlBreast25
Kevin Kalinsky, MD, MS, FASCO retweeted
Still time to register! Join our esteemmed faculty @EmoryUniversity @WinshipAtEmory Updates in #HNCA acrobat.adobe.com/id/urn:aai… on September 6th; @StokedStokes @NikkiSchmittMD @ConorSteuerMD
Kevin Kalinsky, MD, MS, FASCO retweeted
Absolutely outstanding breast cancer session at #DDHO2025. Major themes included treatment de-escalation strategies, adjuvant advances making cure even more possible, and of course lifestyle guidance. I am so incredibly excited to join the remarkable team at @WinshipAtEmory
Kevin Kalinsky, MD, MS, FASCO retweeted
The Glenn Family Breast Cancer Center invites you to the Inaugural Atlanta Breast Cancer Conference on Saturday, September 27, 2025. Learn more and register at bioascend.com/atlanta-breast…
#ATLBreast25
Kevin Kalinsky, MD, MS, FASCO retweeted
📅 Join us tomorrow for our, Expert Analysis of the Top Abstracts From the 2025 Oncology Meeting.
We’re bringing timely, expert-led insights straight to your practice.
✅ Practical strategies for patient care
✅ Designed for oncologists and cancer care teams
✅ CME-accredited
Don’t miss it—register now and be part of the conversation with,
@FordePatrick, @KalinskyKevin, @stolaney1
Register: bit.ly/45H9vwt
Huge congratulations to @DrDawnHershman for receiving the Karnofsky award. Can’t think of a more deserving person. @ASCO
I am much looking forward to this! See you in Chicago.@WinshipAtEmory
Join us in Chicago (or virtually) for our CME Symposium Series in conjunction with the 2025 ASCO® Annual Meeting. Monday night, June 2, join us in person or online for a symposium on metastatic breast cancer. Register: ow.ly/aqV050VXJRx
Kevin Kalinsky, MD, MS, FASCO retweeted
Thank you Representative Williams for supporting #CancerResearch and addressing #drugshortages #priorauths so all #SurvivorsThrive @ASCO @WinshipAtEmory
